A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men

被引:81
作者
Doggen, CJM
Cats, VM
Bertina, RM
Reitsma, PH
Vandenbroucke, JP
Rosendaal, FR
机构
[1] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Cardiol, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Ctr Hemostasis & Thrombosis Res, NL-2300 RC Leiden, Netherlands
关键词
D O I
10.1055/s-0037-1615188
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several studies have examined the relation between factor VII and coronary artery disease by measuring factor VII levels in plasma and some found an association between high levels and disease. This suffers problems of interpretation concerning the causality of high factor VII levels, because factor VII levels may be affected by atherogenic risk factors and may become elevated as a consequence of atherosclerosis. We investigated the association between a genetic variant ((353)Arg-->Gln), shown to be related to factor VII levels, and myocardial infarction in a large case-control study, including 560 cases and 644 controls. Individuals carrying the (353)Arg-Arg genotype seemed to have a lower risk of myocardial infarction (odds ratio 0.80 [95% confidence interval 0.60-1.06]). In this study, we confirmed higher factor VII antigen and activity level in 529 men homozygous for the (353)Arg allele compared with 115 men carriers of the (353)Gln allele (around 20% higher). Our results indicate that a genetic propensity to high factor VII levels is not associated with the risk of myocardial infarction. Since we confirmed the association of the (353)Arg-Arg genotype with higher factor VII levels, we conclude that high levels of factor VII are not a causal determinant of myocardial infarction.
引用
收藏
页码:281 / 285
页数:5
相关论文
共 41 条
  • [1] ARBINI AA, 1994, BLOOD, V84, pA86
  • [2] BALLEISEN L, 1985, THROMB HAEMOSTASIS, V54, P475
  • [3] BALLEISEN L, 1985, THROMB HAEMOSTASIS, V54, P721
  • [4] Plasma factor VII levels are determined by polymorphisms in the factor VII gene
    Bentzen, J
    Bladbjerg, EM
    deMaat, MPM
    Marckmann, P
    [J]. FIBRINOLYSIS, 1996, 10 : 17 - 18
  • [5] Bernardi F, 1996, ARTERIOSCL THROM VAS, V16, P72
  • [6] Contribution of factor VII genotype to activated FVII levels - Differences in genotype frequencies between northern and southern European populations
    Bernardi, F
    Arcieri, P
    Bertina, RM
    Chiarotti, F
    Corral, J
    Pinotti, M
    Prydz, H
    Samama, M
    Sandset, PM
    Strom, R
    Garcia, VV
    Mariani, G
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (11) : 2548 - 2553
  • [7] PREPARATION OF A HUMAN FACTOR-VII DEFICIENT PLASMA
    BERTINA, RM
    ORLANDO, M
    TIEDEMANNALDERKAMP, GHJ
    [J]. THROMBOSIS RESEARCH, 1978, 13 (03) : 537 - 541
  • [8] BOM VJJ, 1986, THROMB HAEMOSTASIS, V56, P343
  • [9] FIBRINOGEN, FACTOR-VII CLOTTING ACTIVITY AND CORONARY-ARTERY DISEASE SEVERITY
    BROADHURST, P
    KELLEHER, C
    HUGHES, L
    IMESON, JD
    RAFTERY, EB
    [J]. ATHEROSCLEROSIS, 1990, 85 (2-3) : 169 - 173
  • [10] FACTOR-VII HYPERACTIVITY IN ACUTE MYOCARDIAL THROMBOSIS - A RELATION TO THE COAGULATION ACTIVATION
    DESOUSA, JC
    AZEVEDO, J
    SORIA, C
    BARROS, F
    RIBEIRO, C
    PARREIRA, F
    CAEN, JP
    [J]. THROMBOSIS RESEARCH, 1988, 51 (02) : 165 - 173